Increased response to TPF chemotherapy promotes immune escape in hypopharyngeal squamous cell carcinoma
Background: There is an urgent need to identify which patients would benefit from TPF chemotherapy in hypopharyngeal squamous cell carcinoma (HPSCC) and to explore new combinations to improve the treatment effect.Materials and methods: Gene-expression profiles in 15 TPF-sensitive patients were compa...
Main Authors: | Ruichen Li, Li Yan, Shu Tian, Yang Zhao, Yi Zhu, Xiaoshen Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1097197/full |
Similar Items
-
Low p16 Cytoplasmic Staining Predicts Poor Treatment Outcome in Patients with p16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving TPF Induction Chemotherapy
by: Yen-Hao Chen, et al.
Published: (2023-01-01) -
Serum Levels of Stromal Cell-Derived Factor-1α and Vascular Endothelial Growth Factor Predict Clinical Outcomes in Head and Neck Squamous Cell Carcinoma Patients Receiving TPF Induction Chemotherapy
by: Yen-Hao Chen, et al.
Published: (2022-03-01) -
Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma
by: Shi-Long Zhang, et al.
Published: (2023-10-01) -
Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers
by: Maureen Bernadach, et al.
Published: (2021-04-01) -
Development and Validation of a Prognostic Nomogram for Hypopharyngeal Carcinoma
by: Shu Tian, et al.
Published: (2021-06-01)